| MeSH term | MeSH ID | Detail |
|---|---|---|
| Telangiectasia, Hereditary Hemorrhagic | D013683 | 1 associated lipids |
| Hemosiderosis | D006486 | 1 associated lipids |
| Rickets, Hypophosphatemic | D063730 | 1 associated lipids |
| Calcium Metabolism Disorders | D002128 | 1 associated lipids |
| Anemia, Neonatal | D000751 | 1 associated lipids |
Glucaric acid
Glucaric acid is a lipid of Fatty Acyls (FA) class. Glucaric acid is associated with abnormalities such as Consumption-archaic term for TB and furuncle. The involved functions are known as Oxidation, Mutation, Process, Cell Growth and Anabolism. Glucaric acid often locates in BL21, Clone and host. The associated genes with Glucaric acid are MIOX gene, ISYNA1 gene, Genome and Candidate Disease Gene. The related experimental models are Knock-out.
Cross Reference
Introduction
To understand associated biological information of Glucaric acid, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
What diseases are associated with Glucaric acid?
Glucaric acid is suspected in and other diseases in descending order of the highest number of associated sentences.
Related references are mostly published in these journals:
| Disease | Cross reference | Weighted score | Related literature |
|---|
Loading... please refresh the page if content is not showing up.
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with Glucaric acid
PubChem Associated disorders and diseases
What pathways are associated with Glucaric acid
Lipid pathways are not clear in current pathway databases. We organized associated pathways with Glucaric acid through full-text articles, including metabolic pathways or pathways of biological mechanisms.
Related references are published most in these journals:
| Pathway name | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
PubChem Biomolecular Interactions and Pathways
Link to PubChem Biomolecular Interactions and PathwaysWhat cellular locations are associated with Glucaric acid?
Visualization in cellular structure
Associated locations are in red color. Not associated locations are in black.
Related references are published most in these journals:
| Location | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What functions are associated with Glucaric acid?
Related references are published most in these journals:
| Function | Cross reference | Weighted score | Related literatures |
|---|
What lipids are associated with Glucaric acid?
There are no associated biomedical information in the current reference collection.
What genes are associated with Glucaric acid?
Related references are published most in these journals:
| Gene | Cross reference | Weighted score | Related literatures |
|---|
What common seen animal models are associated with Glucaric acid?
Knock-out
Knock-out are used in the study 'Evolution-guided optimization of biosynthetic pathways.' (Raman S et al., 2014).
Related references are published most in these journals:
| Model | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
NCBI Entrez Crosslinks
All references with Glucaric acid
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Agarwal R | Ironing out the mystery of nephrotoxicity of parenteral iron. | 2005 | J. Lab. Clin. Med. | pmid:16025083 |
| Sanai T et al. | Effect of saccharated ferric oxide and iron dextran on the metabolism of phosphorus in rats. | 2005 | J. Lab. Clin. Med. | pmid:16025088 |
| Macdougall IC and Roche A | Administration of intravenous iron sucrose as a 2-minute push to CKD patients: a prospective evaluation of 2,297 injections. | 2005 | Am. J. Kidney Dis. | pmid:16112047 |
| Perek N et al. | MRP-1 protein expression and glutathione content of in vitro tumor cell lines derived from human glioma carcinoma U-87-MG do not interact with 99mTc-glucarate uptake. | 2005 | Cancer Biother. Radiopharm. | pmid:16114987 |
| Bontchev RP and Moore RC | Crystal structure and aqueous solubility of ammonium D-glucarate. | 2005 | Carbohydr. Res. | pmid:16043161 |
| Wood DM et al. | Hepatocellular damage following therapeutic intravenous iron sucrose infusion in a child. | 2005 | Ther Drug Monit | pmid:16044093 |
| Sheashaa H et al. | Parenteral iron therapy in treatment of anemia in end-stage renal disease patients: a comparative study between iron saccharate and gluconate. | 2005 | Nephron Clin Pract | pmid:15692217 |
| Keven K et al. | Combination of intravenous iron sucrose and ascorbic acid in hemodialysis patients. | 2005 | Kidney Int. | pmid:15954940 |
| Anbu AT et al. | Low incidence of adverse events following 90-minute and 3-minute infusions of intravenous iron sucrose in children on erythropoietin. | 2005 | Acta Paediatr. | pmid:16431410 |
| Erichsen K et al. | Oral ferrous fumarate or intravenous iron sucrose for patients with inflammatory bowel disease. | 2005 | Scand. J. Gastroenterol. | pmid:16165718 |
| St Peter WL et al. | Trends in intravenous iron use among dialysis patients in the United States (1994-2002). | 2005 | Am. J. Kidney Dis. | pmid:16183420 |
| Liu Y and Reineke TM | Hydroxyl stereochemistry and amine number within poly(glycoamidoamine)s affect intracellular DNA delivery. | 2005 | J. Am. Chem. Soc. | pmid:15740138 |
| Laman CA et al. | Parenteral iron therapy: a single institution's experience over a 5-year period. | 2005 | J Natl Compr Canc Netw | pmid:16316614 |
| Strolin Benedetti M et al. | Induction of endogenous pathways by antiepileptics and clinical implications. | 2005 | Fundam Clin Pharmacol | pmid:16176329 |
| Breymann C | Treatment of iron deficiency anaemia in pregnancy and postpartum with special focus on intravenous iron sucrose complex. | 2005 | J Med Assoc Thai | pmid:17718296 |
| Cuenca J et al. | Role of parenteral iron in the management of anaemia in the elderly patient undergoing displaced subcapital hip fracture repair: preliminary data. | 2005 | Arch Orthop Trauma Surg | pmid:15789233 |
| Tutor-Crespo MJ et al. | Effect of antiepileptic drugs on the urinary excretion of porphyrins in non-porphyric subjects. | 2005 | J. Pharmacol. Sci. | pmid:16314692 |
| Schaller G et al. | Intravenous iron increases labile serum iron but does not impair forearm blood flow reactivity in dialysis patients. | 2005 | Kidney Int. | pmid:16316358 |
| Van Wyck DB et al. | A randomized, controlled trial comparing IV iron sucrose to oral iron in anemic patients with nondialysis-dependent CKD. | 2005 | Kidney Int. | pmid:16316362 |
| Anemia during pregnancy and in the postpartum: intravenous iron therapy revisited. | 2005 | Eur. J. Obstet. Gynecol. Reprod. Biol. | pmid:16360535 | |
| Govan AD and Scott JM | Intravenous iron in the treatment of anemia of pregnancy. 1949. | 2005 | Eur. J. Obstet. Gynecol. Reprod. Biol. | pmid:16360540 |
| Schröder O et al. | Intravenous iron sucrose versus oral iron supplementation for the treatment of iron deficiency anemia in patients with inflammatory bowel disease--a randomized, controlled, open-label, multicenter study. | 2005 | Am. J. Gastroenterol. | pmid:16279906 |
| Sengölge G et al. | Intravenous iron therapy: well-tolerated, yet not harmless. | 2005 | Eur. J. Clin. Invest. | pmid:16281958 |
| Agarwal R | On the nature of proteinuria with acute renal injury in patients with chronic kidney disease. | 2005 | Am. J. Physiol. Renal Physiol. | pmid:15467003 |
| Leijn E et al. | Intravenous iron supplementation in children on hemodialysis. | 2004 May-Jun | J. Nephrol. | pmid:15365964 |
| Verma P et al. | Decolorization of synthetic dyes using a copper complex with glucaric acid. | 2004 | Chemosphere | pmid:14575741 |
| Cuenca J et al. | Patients with pertrochanteric hip fracture may benefit from preoperative intravenous iron therapy: a pilot study. | 2004 | Transfusion | pmid:15383017 |
| Schwenk MH and Blaustein DA | Rapid, high-dose intravenous iron sucrose therapy in 2 Jehovah's Witness patients with severe anemia, iron deficiency and chronic kidney disease. | 2004 | Clin. Nephrol. | pmid:15356968 |
| Tiranathanagul K et al. | Oxidative stress from rapid versus slow intravenous iron replacement in haemodialysis patients. | 2004 | Nephrology (Carlton) | pmid:15363053 |
| McMahon LP et al. | Effects of different dialysis membranes on serum concentrations of epoetin alfa, darbepoetin alfa, enoxaparin, and iron sucrose during dialysis. | 2004 | Am. J. Kidney Dis. | pmid:15332224 |
| Schröder O et al. | A study for the evaluation of safety and tolerability of intravenous high-dose iron sucrose in patients with iron deficiency anemia due to gastrointestinal bleeding. | 2004 | Z Gastroenterol | pmid:15314711 |
| Tutor-Crespo MJ et al. | Possible induction of cholinesterase in epileptic patients treated with anticonvulsant drugs: relationship with lipoprotein levels. | 2004 | J Clin Pharmacol | pmid:15317825 |
| Agarwal R | Transferrin saturation with intravenous irons: an in vitro study. | 2004 | Kidney Int. | pmid:15327409 |
| Aronoff GR et al. | Iron sucrose in hemodialysis patients: safety of replacement and maintenance regimens. | 2004 | Kidney Int. | pmid:15327417 |
| Liu Z et al. | 99mTc glucarate high-resolution imaging of drug sensitive and drug resistant human breast cancer xenografts in SCID mice. | 2004 | Nucl Med Commun | pmid:15208499 |
| Liu Y et al. | New poly(d-glucaramidoamine)s induce DNA nanoparticle formation and efficient gene delivery into mammalian cells. | 2004 | J. Am. Chem. Soc. | pmid:15198572 |
| Zager RA et al. | Parenteral iron nephrotoxicity: potential mechanisms and consequences. | 2004 | Kidney Int. | pmid:15200421 |
| Sengoelge G et al. | Dose-dependent effect of parenteral iron therapy on bleomycin-detectable iron in immune apheresis patients. | 2004 | Kidney Int. | pmid:15200437 |
| Dornyei A et al. | Vanadium(IV,V) complexes of D-saccharic and mucic acids in aqueous solution. | 2004 | Dalton Trans | pmid:15381996 |
| Scheiber-Mojdehkar B et al. | Non-transferrin-bound iron in the serum of hemodialysis patients who receive ferric saccharate: no correlation to peroxide generation. | 2004 | J. Am. Soc. Nephrol. | pmid:15153577 |
| Walaszek Z et al. | Mechanisms of lung cancer chemoprevention by D-glucarate. | 2004 | Chest | pmid:15136472 |
| Hanausek M et al. | Modulation of biomarkers during chemoprevention of mouse lung tumorigenesis by D-glucarate. | 2004 | Chest | pmid:15136473 |
| Silverstein SB and Rodgers GM | Parenteral iron therapy options. | 2004 | Am. J. Hematol. | pmid:15114602 |
| Lakatos A et al. | AlIII ion complexes of saccharic acid and mucic acid: a solution and solid-state study. | 2004 | Chemistry | pmid:15007818 |
| Tutor-Crespo M et al. | Isoforms of serum gamma-glutamyltransferase in epileptic patients treated with enzyme-inducing anticonvulsant drugs. | 2004 | J Pharm Pharm Sci | pmid:15576017 |
| Silverberg D et al. | The use of androgens in anaemia resistant to erythropoietin and i.v. iron in patients with heart and renal failure. | 2004 | Nephrol. Dial. Transplant. | pmid:15031380 |
| Ogi M et al. | [Comparison of intravenous ascorbic acid versus intravenous iron for functional iron deficiency in hemodialysis patients]. | 2004 | Nihon Jinzo Gakkai Shi | pmid:15645737 |
| Guz G et al. | Elevated cardiac troponin T in hemodialysis patients receiving more intravenous iron sucrose. | 2004 | Ren Fail | pmid:15600258 |
| Gupta KP and Singh J | Modulation of carcinogen metabolism and DNA interaction by calcium glucarate in mouse skin. | 2004 | Toxicol. Sci. | pmid:14976333 |
| Borawski J et al. | Endothelial injury markers with high-dose intravenous iron therapy in renal failure. | 2004 | Clin. Appl. Thromb. Hemost. | pmid:15497030 |